Lastacaft label

Lastacaft

Lastacaft Recall

Get an alert when a recall is issued.

Add Info

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

LASTACAFT™ is an H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

LASTACAFT™ is a sterile, topically administered H1 receptor antagonist containing alcaftadine for ophthalmic use.

Alcaftadine is a white to yellow powder with an empirical formula of C19H21N3O and a molecular weight of 307.39.

Contains: Active: alcaftadine 0.25% (2.5 mg/mL). Preservative: benzalkonium chloride 0.005%. Inactives: edetate disodium, monobasic sodium phosphate, purified water, sodium chloride, sodium hydroxide and/or hydrochloric acid to adjust pH

Chemical Name: 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5H-imidazo[2,1-b] [3] benzazepine-3-carboxaldehyde

Structural Formula:

Structural Formula

The drug product has a pH of approximately 7 and an osmolality of approximately 290 mOsm/kg.

Add Info
Add to My Alerts
Report Side Effect
Leave a Review
Navigate to :
Lastacaft Recall
Side Effects & Adverse Reactions
Legal Issues
FDA Safety Alerts
Manufacturer Warnings
FDA Labeling Changes
Uses
History
Other Information
Manufacturers
Trending Topics

Lastacaft Manufacturers

  • Physicians Total Care, Inc.
    Lastacaft | Physicians Total Care, Inc.
    No Recall

    Lastacaft | Physicians Total Care, Inc.

    Lastacaft | Physicians Total Care, Inc.

    Instill one drop in each eye once daily.

  • Rebel Distributors Corp
    Lastacaft | Rebel Distributors Corp
    No Recall

    Lastacaft | Rebel Distributors Corp

    Lastacaft | Rebel Distributors Corp

    Instill one drop in each eye once daily.

  • Allergan, Inc.
    Lastacaft | Allergan, Inc.
    No Recall

    Lastacaft | Allergan, Inc.

    Lastacaft | Allergan, Inc.
    2.1 Recommended Dosing

    Patient Dosing

    One drop of ACUVAIL® should be applied to the affected eye twice daily beginning 1 day prior to cataract surgery, continued on the day of surgery, and through the first 2 weeks of the postoperative period.

    2.2 Use With Other Topical Ophthalmic Medications

    ACUVAIL® ophthalmic solution may be administered in conjunction with other topical ophthalmic medications such as alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics. Drops should be administered at least 5 minutes apart.

Login To Your Free Account